Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year

Thrombosis Research

Volumn 134, Issue 5, 2014, Pages 1093-1096

  Thaler, Johannes ^a   Koppensteiner, Renate ^a   Pabinger, Ingrid ^a   Ay, Cihan ^a   Gremmel, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Deep vein thrombosis; Lower limb; Microparticles; Tissue factor; Venous thromboembolism

Indexed keywords

THROMBOPLASTIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LEG THROMBOSIS; LONGITUDINAL STUDY; LUNG EMBOLISM; MALE; MEMBRANE MICROPARTICLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; STRUCTURED INTERVIEW; ACUTE DISEASE; BLOOD; BLOOD CLOTTING; METABOLISM; MIDDLE AGED; PATHOLOGY; VEIN THROMBOSIS;

ACUTE DISEASE; ADULT; BLOOD COAGULATION; CELL-DERIVED MICROPARTICLES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBOPLASTIN; VENOUS THROMBOSIS;

EID: 84927582650     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.07.041     Document Type: Article

References (31)

1. Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol 2008; 28:387-91.
2. Mackman N. New insights into the mechanisms of venous thrombosis. J Clin Invest 2012; 122:2331-6.
3. Bovill EG, van der Vliet A. Venous valvular stasis-associated hypoxia and thrombosis: what is the link? Annu Rev Physiol 2011; 73:527-45.
4. Mackman N. Triggers, targets and treatments for thrombosis. Nature 2008; 451: 914-8.
5. Wu O, Robertson L, Langhorne P., Twaddle S, Lowe GD, Clark P, et al. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thromb Haemost 2005; 94:17-25.
6. Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 2007; 5:520-7.
7. Manly DA, Wang J, Glover S.L., Kasthuri R., Liebman HA, Key NS, et al. Increased micro-particle tissue factor activity in cancer patients with Venous Thromboembolism. Thromb Res 2010; 125:511-2.
8. Tesselaar ME, Romijn FP, van der Linden IK, Bertina RM, Osanto S. Microparticle-associated tissue factor activity in cancer patients with and without thrombosis. J Thromb Haemost 2009; 7:1421-3.
9. Langer F, Spath B, Haubold K., Holstein K, Marx G, Wierecky J., et al. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation. Ann Hematol 2008; 87:451-7.
10. Thaler J, Pabinger I, Sperr W.R., Ay C. Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia. Thromb Res 2014; 133:303-5.
11. Key NS, Slungaard A, Dandelet L., Nelson SC, Moertel C, Styles LA, et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998; 91:4216-23.
12. Ames PR, Antinolfi I, Ciampa A., Batuca J, Scenna G, Lopez L.R., et al. Primary antiphospholipid syndrome: a low-grade auto-inflammatory disease? Rheumatology (Oxford) 2008; 47:1832-7.
13. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013; 13:34-45.
14. Khorana AA, Francis CW, Menzies K.E., Wang JG, Hyrien O, Hathcock J, et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 2008; 6:1983-5.
15. Dvorak HF, Van DeWater L, Bitzer AM, Dvorak A.M., Anderson D., Harvey VS, et al. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 1983; 43:4434-42.
16. Kadish JL, Wenc KM, Dvorak HF. Tissue factor activity of normal and neoplastic cells: quantitation and species specificity. J Natl Cancer Inst 1983; 70:551-7.
17. Giesen PL, Rauch U, Bohrmann B., Kling D, Roque M, Fallon J.T., et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 1999; 96:2311-5.
18. Bogdanov VY, Balasubramanian V, Hathcock J., Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9:458-62.
19. Butenas S, Bouchard BA, Brummel-Ziedins KE, Parhami-Seren B, Mann KG. Tissue factor activity in whole blood. Blood 2005; 105:2764-70.
20. Ay C, Freyssinet JM, Sailer T, Vormittag R., Pabinger I. Circulating procoagulant micro-particles in patients with venous thromboembolism. Thromb Res 2009; 123:724-6.
21. Garcia Rodriguez P, Eikenboom HC, Tesselaar M.E., Huisman MV, Nijkeuter M, Osanto S, et al. Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism. Thromb Res 2010; 126:345-9.
22. Thaler J, Ay C, Mackman N., Bertina RM, Kaider A, Marosi C, et al. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost 2012; 10: 1363-70.
23. Thaler J, Ay C, Mackman N., Metz-Schimmerl S, Stift J, Kaider A., et al. Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features. Eur J Clin Invest 2013; 43:277-85.
24. Willemze R, Bradford RL, Mooberry M.J., Roubey RA, Key NS. Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications. Thromb Res 2013; 133:187-9.
25. Thaler J, Koder S, Kornek G., Pabinger I, Ay C. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation. Transl Res 2014; 163:145-50.
26. Lee RD, Barcel DA, Williams J.C., Wang JG, Boles JC, Manly DA, et al. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. Thromb Res 2012; 129:80-5.
27. Mann KG, Orfeo T, Butenas S., Undas A, Brummel-Ziedins K. Blood coagulation dynamics in haemostasis. Hamostaseologie 2009; 29:7-16.
28. Lawrie AS, Albanyan A, Cardigan R.A., Mackie IJ, Harrison P. Microparticle sizing by dynamic light scattering in fresh-frozen plasma. Vox Sang 2009; 96:206-12.
29. Yuana Y, Oosterkamp TH, Bahatyrova S, Ashcroft B., Garcia Rodriguez P, Bertina RM, et al. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemost 2010; 8:315-23.
30. Zwicker JI, Liebman HA, Neuberg D, Lacroix R., Bauer KA, Furie BC, et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thrombo-embolic events in malignancy. Clin Cancer Res 2009; 15:6830-40.
31. Hernandez C, Orbe J, Roncal C., Alvarez-Hernandez M, Martinez de Lizarrondo S, Alves MT, et al. Tissue factor expressed by microparticles isassociated with mortality but not with thrombosis in cancer patients. Thromb Haemost 2013; 110:598-608.